Childhood IgA Nephropathy Successfully Treated with Targeted‐Release Budesonide: A Case Report
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Paediatrics and Child Health"
DOI: 10.1111/jpc.14259
Abstract: Idiopathic immunoglobulin-A (IgA) nephropathy is a primary glomerulonephritis with varying clinical presentations. Treatment regimens are often poorly tolerated and yield variable results. The NEFIGAN Trial (targeted-release budesonide vs. placebo in patients with IgA nephropathy) demonstrated… read more here.
Keywords: trial; iga nephropathy; release budesonide; targeted release ... See more keywords
Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1)
Sign Up to like & getrecommendations! Published in 2020 at "United European Gastroenterology Journal"
DOI: 10.1177/2050640620962632
Abstract: Background In patients with mesalazine-refractory ulcerative colitis, systemic corticosteroids are the treatment of choice. Objective To evaluate the efficacy and safety of prolonged release budesonide granules for the induction of remission in patients with mesalazine-refractory… read more here.
Keywords: week; release budesonide; refractory ulcerative; ulcerative colitis ... See more keywords